These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 35261189)
1. Association of Cardiac Biomarkers With Cardiovascular Outcomes in Patients With Psoriatic Arthritis and Psoriasis: A Longitudinal Cohort Study. Colaco K; Lee KA; Akhtari S; Winer R; Welsh P; Sattar N; McInnes IB; Chandran V; Harvey P; Cook RJ; Gladman DD; Piguet V; Eder L Arthritis Rheumatol; 2022 Jul; 74(7):1184-1192. PubMed ID: 35261189 [TBL] [Abstract][Full Text] [Related]
2. Value of Carotid Ultrasound in Cardiovascular Risk Stratification in Patients With Psoriatic Disease. Sobchak C; Akhtari S; Harvey P; Gladman D; Chandran V; Cook R; Eder L Arthritis Rheumatol; 2019 Oct; 71(10):1651-1659. PubMed ID: 31165591 [TBL] [Abstract][Full Text] [Related]
3. Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients. Eriguchi M; Tsuruya K; Lopes M; Bieber B; McCullough K; Pecoits-Filho R; Robinson B; Pisoni R; Kanda E; Iseki K; Hirakata H ESC Heart Fail; 2022 Apr; 9(2):1138-1151. PubMed ID: 35026869 [TBL] [Abstract][Full Text] [Related]
4. Predictors of 10-year changes in levels of N-terminal pro B-type natriuretic peptide and cardiac troponin I in the elderly. Eggers KM; Lindahl B; Venge P; Lind L Int J Cardiol; 2018 Apr; 257():300-305. PubMed ID: 29506712 [TBL] [Abstract][Full Text] [Related]
5. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA). Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639 [TBL] [Abstract][Full Text] [Related]
6. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease. Hamaya R; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Kanno Y; Murai T; Lee T; Kakuta T Heart Vessels; 2019 Mar; 34(3):410-418. PubMed ID: 30229410 [TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study. Cheng H; Fan WZ; Wang SC; Liu ZH; Zang HL; Wang LZ; Liu HJ; Shen XH; Liang SQ J Crit Care; 2015 Jun; 30(3):654.e9-14. PubMed ID: 25575850 [TBL] [Abstract][Full Text] [Related]
8. Can serum level of N-terminal pro B-type natriuretic peptide be used in patients with psoriasis as a predictor of cardiovascular disease? Shahidi-Dadras M; Niknezhad N; Niknejad N; Zargari O Dermatol Ther; 2019 May; 32(3):e12865. PubMed ID: 30838740 [TBL] [Abstract][Full Text] [Related]
9. The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease. Eder L; Chandran V; Gladman DD Ann Rheum Dis; 2014 Nov; 73(11):1990-6. PubMed ID: 23887287 [TBL] [Abstract][Full Text] [Related]
10. Comparison of cardiac biomarkers on risk assessment of contrast-associated acute kidney injury in patients undergoing cardiac catheterization: A multicenter retrospective study. Yu S; Li Q; He Y; Jia C; Liang G; Lu H; Wu W; Liu J; Liu Y; Chen J Nephrology (Carlton); 2023 Nov; 28(11):588-596. PubMed ID: 37619965 [TBL] [Abstract][Full Text] [Related]
11. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients. Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079 [TBL] [Abstract][Full Text] [Related]
12. Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Shafi T; Zager PG; Sozio SM; Grams ME; Jaar BG; Christenson RH; Boulware LE; Parekh RS; Powe NR; Coresh J Am J Kidney Dis; 2014 Sep; 64(3):443-51. PubMed ID: 24787760 [TBL] [Abstract][Full Text] [Related]
13. Seemingly healthy 71-year-old men with minor elevations of cardiac troponin I and at risk of premature death in CVD have elevated levels of NT-proBNP: report from the ULSAM study. Venge P; Arnlöv J; Zethelius B Scand J Clin Lab Invest; 2009; 69(3):418-24. PubMed ID: 19221927 [TBL] [Abstract][Full Text] [Related]
14. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications. Pareek M Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244 [TBL] [Abstract][Full Text] [Related]
15. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Apple FS; Murakami MM; Pearce LA; Herzog CA Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888 [TBL] [Abstract][Full Text] [Related]
16. Rapid rule out of acute myocardial infarction in the observe zone using a combination of presentation N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin I. Wang Y; Dai L; Wang N; Zhu Y; Chen M; Wang H Clin Biochem; 2019 Aug; 70():34-38. PubMed ID: 31173734 [TBL] [Abstract][Full Text] [Related]
17. Increased serum level of N-terminal Pro-B-type natriuretic peptide as a possible biomarker of cardiovascular risk in psoriatic patients. Pietrzak A; Bartosinska J; Blaszczyk R; Chodorowska G; Brzozowski W; Hercogova J; Donica H; Lotti T J Eur Acad Dermatol Venereol; 2015 May; 29(5):1010-4. PubMed ID: 24735175 [TBL] [Abstract][Full Text] [Related]